An IL-15 superagonist shows promise
New adjuvant therapies, advances in neoadjuvant
Men with the HSD3B1(1245C) variant metabolize abiraterone differently
13-year retrospective shows evolution of treatment for aggressive disease
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A novel strategy for radiation therapy planning
Tc9 cells have less intracellular cholesterol than other T cells
Moving radiotherapy beyond a one-size-fits-all approach
Tips for counseling patients included throughout new guidelines
Results based on early data from clinical trial
Early results presented at ASCO 2018
Advertisement
Advertisement